Reciprocal human dendritic cell-natural killer cell interactions induce antitumor activity following tumor cell

Robin J Prestwich1, Fiona Errington, Lynette P Steele

  • 1Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom;

Insights

Reovirus therapy activates dendritic cells (DCs) to recruit and activate natural killer (NK) cells, enhancing antitumor immunity. This study reveals how reovirus-infected tumor cells stimulate DCs, leading to robust NK cell-mediated tumor cell killing.

Area of Science:

  • Immunology
  • Virology
  • Cancer Therapy

Background:

  • Oncolytic virotherapy uses viruses to fight cancer, but its impact on the innate immune system is not fully understood.
  • Reovirus therapy's ability to generate adaptive antitumor immunity is known, yet its innate immune interactions require further investigation.

Purpose of the Study:

  • To investigate the innate immunological effects of reovirus therapy using a human in vitro system.
  • To explore the potential of reovirus therapy to activate natural killer (NK) cell-mediated antitumor activity.

Main Methods:

  • Utilized a human in vitro system involving dendritic cells (DCs) loaded with reovirus-infected melanoma cells (DC-MelReo).
  • Co-cultured DC-MelReo with peripheral blood mononuclear cells (PBMCs) and purified NK cells to assess immune responses.
  • Measured cytokine production, chemokine secretion, cell-to-cell contact-dependent interactions, and NK cell activation markers (CD69).

Main Results:

  • DC-MelReo induced IFN-gamma production in NK cells and secreted chemokines (CCL2, 3, 4, 5, 7, 8, 11, CXCL10) that promoted NK cell chemotaxis.
  • Reciprocal DC maturation and NK cell activation (CD69 up-regulation) occurred upon co-culture, dependent on cell contact and IL-12.
  • DC-MelReo treatment led to type I IFN-dependent NK cell cytotoxicity against tumor cells.

Conclusions:

  • Reovirus infection of tumor cells can activate DCs, which in turn recruit, activate, and enhance NK cell cytotoxicity.
  • Reciprocal interactions between DCs and NK cells following reovirus therapy may significantly alter the tumor microenvironment.
  • These DC-NK cell interactions are crucial for mediating tumor regression in oncolytic virotherapy.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...